Clinical Trial Update: The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing a neutral peritoneal dialysis solution with minimal glucose-degradation-products on fluid status and body composition has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Neutral Peritoneal Dialysis Solution with Minimal Glucose-Degradation-Product (GDP)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Renal Failure, ESRD | Phase 4 | Status: COMPLETED